EPISODE · Sep 4, 2020 · 6 MIN
Dr Philip Hamann on RA trajectories, real world data and AI
from The Rheumatology Podcast · host Oxford University Press
Dr James Galloway asks Dr Philip Hamann (University of Bristol, UK) about his recent paper, which identifies disease activity trajectories in RA patients receiving their first anti-TNF. They discuss the paper’s key findings and the challenges of working with real world data, as well as Dr Hamann’s work as a Turing Fellow.
Embed this episode
NOW PLAYING
Dr Philip Hamann on RA trajectories, real world data and AI
0:00
6:39
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Rheumatology Podcast?
This episode is 6 minutes long.
When was this The Rheumatology Podcast episode published?
This episode was published on September 4, 2020.
Can I download this The Rheumatology Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!